Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib

被引：13

作者：

Lin, F ^{[1
]}

Drummond, M ^{[1
]}

O'Brien, S ^{[1
]}

Cervantes, F ^{[1
]}

Goldman, J ^{[1
]}

Kaeda, J ^{[1
]}

机构：

[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Haematol, London W12 0NN, England

来源：

BLOOD | 2003年 / 102卷 / 03期

关键词：

D O I：

10.1182/blood-2002-12-3916

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1143 / 1143

页数：1

共 7 条

[1] Complete molecular remission in chronic myelogenous leukemia after imatinib therapy [J].

Barbany, G ;

Höglund, M ;

Simonsson, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :539-540

[2]

CROSS NCP, 1993, BLOOD, V82, P1929

[3]

Hochhaus A, 2000, BLOOD, V95, P62

[4] Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia [J].

Kaeda, J ;

Chase, A ;

Goldman, JM .

ACTA HAEMATOLOGICA, 2002, 107 (02) :64-75

[5]

Mensink E, 1998, BRIT J HAEMATOL, V102, P768

[6] Quantifying leukemia [J].

Morley, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :627-629

[7] Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia [J].

O'Brien, SG ;

Guilhot, F ;

Larson, RA ;

Gathmann, I ;

Baccarani, M ;

Cervantes, F ;

Cornelissen, JJ ;

Fischer, T ;

Hochhaus, A ;

Hughes, T ;

Lechner, K ;

Nielsen, JL ;

Rousselot, P ;

Reiffers, J ;

Saglio, G ;

Shepherd, J ;

Simonsson, B ;

Gratwohl, A ;

Goldman, JM ;

Kantarjian, H ;

Taylor, K ;

Verhoef, G ;

Bolton, AE ;

Capdeville, R ;

Druker, BJ ;

Durrant, S ;

Schwarer, A ;

Joske, D ;

Seymour, J ;

Grigg, A ;

Ma, D ;

Arthur, C ;

Bradstock, K ;

Joshua, D ;

Louwagie, A ;

Martiat, P ;

Straetmans, N ;

Bosly, A ;

Shustik, C ;

Lipton, J ;

Forrest, D ;

Walker, I ;

Roy, DC ;

Rubinger, M ;

Bence-Bruckler, I ;

Kovacs, M ;

Turner, AR ;

Birgens, H ;

Bjerrum, O ;

Facon, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :994-1004

← 1 →